Ministry of Health is withdrawing approval for the above mentioned product with effect from 1 May 2020. It will be delisted from Pharmaceutical Schedule 1 May 2020.

Exert from New Zealand Doctor 21 November 2019:-

On 20 November, Medsafe issued an alert that Cafergot, which has been used for about 50 years, is no longer regarded as a suitable treatment as better treatments are now available. The product affected is Cafergot, supplied by AFT Pharmaceuticals.

A review recommended removing approval for the medicine to be sold here, and Medsafe is now notifying health professionals that the medicine will no longer be available from May 1 next year.

As of the date of this notification ProPharma / PWR cannot accept Cafergot Tablets for credit under any circumstances.

We thank you in anticipation of your ongoing support.

About The Author